StoxSunrest Lifescience Limited
NSE: SUNREST · Unclassified
Ask the data
Instant answers about Sunrest Lifescience Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY25 | FY26 | |
|---|---|---|
| Revenue | 33.4 | 70.8 |
| EBITDA | 3.0 | 10.2 |
| Operating margin | 9.0% | 14.4% |
| Interest | 0.3 | 1.4 |
| Depreciation | 0.1 | 1.2 |
| Profit before tax | 2.6 | 10.1 |
| Tax | 0.6 | 2.1 |
| Net profit | 2.0 | 4.1 |
| EPS ₹ | 0.00 | 9.59 |
| Operating cash flow | 2.9 | -0.1 |
| Capex | 1.4 | 7.5 |
| Dividend paid | 0.0 | 0.0 |
| Total assets | 58.6 | 71.4 |
| Equity | 16.3 | 20.4 |
Half-yearly performance
last 4 half years · ₹ crore| H1 FY25* | H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|---|
| Revenue | 33.4 | 0.0 | 34.0 | 36.8 |
| Operating profit | 3.0 | 0.0 | 2.5 | 6.8 |
| Operating margin | 9.0% | — | 7.2% | 18.4% |
| Other income | 0.0 | 0.0 | 0.0 | 2.5 |
| Interest | 0.3 | 0.0 | 0.7 | 0.7 |
| Depreciation | 0.1 | 0.0 | 0.7 | 0.5 |
| Profit before tax | 2.6 | 0.0 | 1.1 | 8.1 |
| Tax | 0.6 | 0.0 | 0.4 | 1.5 |
| Net profit | 2.0 | 0.0 | 0.3 | 3.4 |
| EPS ₹ | 0.00 | 0.00 | 1.57 | 0.79 |
| Revenue YoY | — | — | 1.8% | — |
| Profit YoY | — | — | -83.1% | — |
Returns & margins
trailing-twelve-month, per half year| H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|
| ROE | 12.3% | 2.0% | 18.2% |
| ROCE | 10.3% | 5.5% | 27.8% |
| Net margin | 6.0% | 1.0% | 5.3% |
| EBITDA margin | 9.0% | 7.2% | 13.0% |
| Debt / equity | 0.74 | 0.94 | 0.85 |
| Interest coverage | 9.45 | 2.46 | 7.41 |
| Asset turnover | 0.57 | 0.57 | 0.99 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|
| Share capital | 4.3 | 4.3 | 4.3 |
| Other equity / reserves | 12.0 | 12.4 | 16.1 |
| Total equity | 16.3 | 16.6 | 20.4 |
| Borrowings | 12.1 | 15.7 | 17.5 |
| Current liabilities | 30.9 | 26.6 | 29.5 |
| Non-current liabilities | 6.1 | 10.9 | 12.3 |
| Total assets | 58.6 | 59.8 | 71.4 |
| Property, plant & equipment | 4.4 | 8.2 | 8.5 |
| Investments | 0.0 | 0.0 | 0.0 |
| Inventories | 9.6 | 11.3 | 17.1 |
| Receivables | 36.4 | 29.3 | 32.5 |
| Cash & equivalents | 1.7 | 1.0 | 2.8 |
Cash flow
annual · ₹ crore · line = free cash flow| FY25 | FY26 | |
|---|---|---|
| Cash from operations | 2.9 | -0.1 |
| Cash from investing | -1.1 | -2.9 |
| Cash from financing | -0.3 | 4.0 |
| Capex | 1.4 | 7.5 |
| Free cash flow | 1.6 | -7.6 |
| Dividends paid | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Sunrest Lifescience Limited | 152 | 35.50 | 40.8 | 7.43 | 18.2% |
StoxGud checklist: Bearish setup · 3/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Sunrest Lifescience Limited?
Sunrest Lifescience Limited (SUNREST) closed at ₹35.50 on NSE on 04 Nov 2026.
What is the market cap of Sunrest Lifescience Limited?
₹152 crore at the latest close.
What is the P/E ratio of Sunrest Lifescience Limited?
40.8, on trailing-twelve-month earnings from its filings.
How fast is Sunrest Lifescience Limited growing?
Not enough filed history yet to measure Sunrest Lifescience Limited's growth.
How profitable is Sunrest Lifescience Limited?
On a trailing-twelve-month basis return on equity is 18.2%, return on capital employed 27.8%, operating margin 13.0%, net margin 5.3%.
How much debt does Sunrest Lifescience Limited have?
Sunrest Lifescience Limited is moderately geared: debt to equity is 0.85 with borrowings of ₹17 cr against cash of ₹3 cr (balance sheet of 2026-03-31). Operating profit covers interest 7.4 times.
Financials parsed from Sunrest Lifescience Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY25, annual from FY25, balance sheet from Mar '25. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.